Αρχική σελίδα » Έρευνα » Ομάδα Αιματολογίας » Επιλεγμένες Δημοσιεύσεις

Ομάδα Αιματολογίας-Επιλεγμένες Δημοσιεύσεις

  • Maratheftis CI, Andreakos E, Moutsopoulos HM, Voulgarelis M. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes. Clin Cancer Res. 2007;13:1154-60.

  • Boula A, Voulgarelis M, Giannouli S, Katrinakis G, Psyllaki M,Pontikoglou C, Markidou F, Eliopoulos GD, Papadaki HA. Effect of cA2 anti-tumor necrosis factor-alpha antibody therapy onhematopoiesis of patients with myelodysplastic syndromes. Clin Cancer Res. 2006;12:3099-108.

  • Maratheftis CI, Bolaraki PE, Giannouli S, Kapsogeorgou EK,Moutsopoulos HM, Voulgarelis M. Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) in myelodysplastic hematopoietic progenitor cells. Leuk Res. 2006;30:1177-86.

  • Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis.Arch Intern Med. 2005;165:2337-44.

  • Giannouli S, Tzoanopoulos D, Ritis K, Kartalis G, MoutsopoulosHM, Voulgarelis M. Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatoryfactor-1 (IRF-1) expression. Ann Rheum Dis. 2004;63:578-82.

  • Ioanna Stergiou, Konstantinos Kambas, Stavroula Giannouli, Theodora Katsila, Aglaia Dimitrakopoulou, Veroniki Vidali, Evgenia Synolaki, Aristea Papageorgiou, Andrianos Nezos, George Patrinos, Paschalis Sidera,Konstantinos Ritis, George Vassilopoulos, Athanasios Tzioufas and Michael Voulgarelis. Autophagy in myelodysplastic syndromes: the role of HIF-1α/REDD1 molecular pathway. Blood 2018 132:1808; doi: https://doi.org/10.1182/blood-2018-99-11281